Novel Association between Vasoactive Intestinal Peptide and CRTH2 Receptor in Recruiting Eosinophils A POSSIBLE BIOCHEMICAL MECHANISM FOR ALLERGIC EOSINOPHILIC INFLAMMATION OF THE AIRWAYS

被引:29
作者
El-Shazly, Amr E. [1 ]
Begon, Dominique Y. [3 ]
Kustermans, Gaelle [3 ]
Arafa, Mohammad [3 ]
Dortu, Estelle [3 ]
Henket, Monique [2 ]
Lefebvre, Philippe P.
Louis, Renaud [2 ]
Delvenne, Philippe [3 ]
机构
[1] Liege Univ Hosp, Rhinol Unit, Dept Otorhinolaryngol & Head & Neck Surg, CHU, B-4000 Liege, Belgium
[2] Liege Univ Hosp, CHU, Dept Pulmonol, GIGA Res, B-4000 Liege, Belgium
[3] Univ Liege, Lab Expt Pathol, Dept Pathol, GIGA Canc, B-4000 Liege, Belgium
关键词
SUBSTANCE-P; 2B4; CD244; CHEMOTAXIS; CELLS; EXPRESSION; MIGRATION; MOLECULE; KINASE;
D O I
10.1074/jbc.M112.422675
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
We explored the relation between vasoactive intestinal peptide (VIP), CRTH2, and eosinophil recruitment. It is shown that CRTH2 expression by eosinophils from allergic rhinitis (AR) patients and eosinophil cell line (Eol-1 cells) was up-regulated by VIP treatment. This was functional and resulted in exaggerated migratory response of cells against PGD2. Nasal challenge of AR patients resulted in a significant increase of VIP contents in nasal secretion (ELISA), and the immunohistochemical studies of allergic nasal tissues showed significant expression of VIP in association with intense eosinophil recruitment. Biochemical assays showed that VIP-induced eosinophil chemotaxis from AR patients and Eol-1 cells was mediated through the CRTH2 receptor. Cell migration against VIP was sensitive to protein kinaseC(PKC) and protein kinaseA(PKA) inhibition but not to tyrosine kinase or p38 MAPK inhibition or calcium chelation. Western blot demonstrated a novel CRTH2-mediated cytosol-to-membrane translocation of PKC-epsilon, PKC-delta, and PKA-alpha, -gamma, and -II alpha reg in Eol-1 cells upon stimulation with VIP. Confocal images and FACS demonstrated a strong association and co-localization between VIP peptide and CRTH2 molecules. Further, VIP induced PGD2 secretion from eosinophils. Our results demonstrate the first evidence of association between VIP and CRTH2 in recruiting eosinophils.
引用
收藏
页码:1374 / 1384
页数:11
相关论文
共 34 条
[1]
RANTES induces tyrosine kinase activity of stably complexed p125(FAK) and ZAP-70 in human T cells [J].
Bacon, KB ;
Szabo, MC ;
Yssel, H ;
Bolen, JB ;
Schall, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :873-882
[2]
VASOACTIVE-INTESTINAL-PEPTIDE IN HUMAN NASAL-MUCOSA [J].
BARANIUK, JN ;
LUNDGREN, JD ;
OKAYAMA, M ;
MULLOL, J ;
MERIDA, M ;
SHELHAMER, JH ;
KALINER, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :825-831
[3]
CHEMOATTRACTANT SIGNALING AND LEUKOCYTE ACTIVATION [J].
BOKOCH, GM .
BLOOD, 1995, 86 (05) :1649-1660
[4]
MECHANISMS OF LEUKOCYTE MOTILITY AND CHEMOTAXIS [J].
DOWNEY, GP .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (01) :113-124
[5]
Signaling in neuropeptide-induced migration of human eosinophils [J].
Dunzendorfer, S ;
Meierhofer, C ;
Wiedermann, CJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (06) :828-834
[6]
Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma [J].
El-Shazly, A ;
Berger, P ;
Girodet, PO ;
Ousova, O ;
Fayon, M ;
Vernejoux, JM ;
Marthan, R ;
Tunon-de-Lara, JM .
JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1860-1868
[7]
Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate [J].
El-Shazly, A ;
Masuyama, K ;
Samejima, Y ;
Eura, M ;
Ishikawa, T .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 117 :10-13
[8]
2B4 (CD244) IS INVOLVED IN EOSINOPHIL ADHESION AND CHEMOTAXIS, AND ITS SURFACE EXPRESSION IS INCREASED IN ALLERGIC RHINITIS AFTER CHALLENGE [J].
El-Shazly, A. E. ;
Henket, M. ;
Lefebvre, P. P. ;
Louis, R. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (04) :949-960
[9]
IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor [J].
El-Shazly, A. E. ;
Moonen, V. ;
Mawet, M. ;
Begon, D. ;
Henket, M. ;
Arafa, M. ;
Louis, R. ;
Delvenne, P. ;
Lefebvre, P. P. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (11) :1864-1870
[10]
El-Shazly Amr, 2000, Allergology International, V49, P19, DOI 10.1046/j.1440-1592.2000.00154.x